Answers are grounded in this paper and cite their sources.
Heterotopic ossification (HO) following hip arthroscopy is a common finding. Naproxen and celecoxib have both been found to decrease the incidence of HO. Whether this makes a clinical difference to outcomes is unclear at this time. A critical weighing of risks and benefits with regard to HO prophylaxis is warranted. Although the authors will personally continue to use nonsteroidal anti-inflammatory drugs for HO prophylaxis, it is up to the discerning reader to draw her/his own conclusion.
No takes yet. Share an insight, caveat, or question.
Ochiai et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: